Abbott India Ltd. Technical Momentum Shifts Amid Mixed Market Signals

Price Momentum and Recent Market Performance

On 5 Mar 2026, Abbott India’s share price closed at ₹27,818.15, marking a 3.69% increase from the previous close of ₹26,827.45. The intraday range saw a high of ₹27,931.00 and a low of ₹26,498.20, reflecting heightened volatility. Despite this uptick, the stock remains below its 52-week high of ₹35,921.55, while comfortably above its 52-week low of ₹26,000.00.

Comparatively, Abbott India has outperformed the Sensex in the short term, delivering a 5.32% return over the past week against the Sensex’s decline of 3.84%. Over the one-month horizon, the stock gained 2.58%, while the Sensex fell 5.61%. However, longer-term returns reveal a more nuanced picture: the stock is down 11.02% over the past year, contrasting with the Sensex’s 8.39% gain. Over three and five years, Abbott India has outpaced the benchmark with returns of 38.03% and 89.94%, respectively, underscoring its resilience in the pharmaceutical sector.

Technical Indicator Analysis: MACD and RSI

The Moving Average Convergence Divergence (MACD) indicator remains bearish on the weekly chart but has improved to mildly bearish on the monthly timeframe. This suggests that while short-term momentum is still under pressure, longer-term trends are beginning to stabilise. The MACD histogram shows a narrowing gap between the MACD line and the signal line, indicating a potential shift towards bullish momentum if the trend continues.

The Relative Strength Index (RSI) presents a neutral stance, with no clear signal on both weekly and monthly charts. This lack of directional bias implies that the stock is neither overbought nor oversold, providing a balanced environment for potential price movements. Investors should monitor RSI closely for any divergence or breakout that could signal a stronger directional move.

Moving Averages and Bollinger Bands

Daily moving averages currently indicate a mildly bearish trend, with the stock price hovering near the short-term averages but still below key resistance levels. The 50-day moving average remains a critical level to watch, as a sustained break above it could confirm a technical recovery.

Bollinger Bands on both weekly and monthly charts are mildly bearish, reflecting moderate volatility and a slight downward bias. The bands have contracted recently, signalling reduced price volatility, which often precedes a significant price move. Traders should be alert for a breakout above the upper band as a bullish confirmation or a breakdown below the lower band signalling further weakness.

Additional Technical Signals: KST, Dow Theory, and OBV

The Know Sure Thing (KST) oscillator remains bearish on the weekly chart but has improved to mildly bearish on the monthly timeframe, mirroring the MACD’s directional cues. This suggests that momentum is gradually shifting, albeit with caution.

Dow Theory assessments also indicate a mildly bearish trend on both weekly and monthly charts, reflecting the broader market’s cautious stance towards the pharmaceutical sector. This aligns with the mixed technical signals and highlights the importance of monitoring trend confirmations before committing to a position.

On-Balance Volume (OBV) shows a mildly bearish trend on the weekly chart but no clear trend on the monthly scale. This divergence between price and volume suggests that while selling pressure has eased recently, accumulation has not yet gained significant traction.

Mojo Score and Market Capitalisation Insights

Abbott India’s current Mojo Score stands at 50.0, reflecting a neutral stance with a Mojo Grade upgraded from Sell to Hold as of 4 Mar 2026. This upgrade signals improving technical and fundamental conditions, though the stock remains in a cautious zone. The company’s Market Cap Grade is 2, indicating a mid-tier market capitalisation relative to its peers in the Pharmaceuticals & Biotechnology sector.

Investors should note that the stock’s recent 3.69% day change reflects renewed buying interest, possibly driven by the technical parameter shifts and sectoral tailwinds. However, the mixed signals across multiple indicators warrant a measured approach.

Sector and Industry Context

Operating within the Pharmaceuticals & Biotechnology sector, Abbott India faces both opportunities and challenges. The sector has experienced volatility due to regulatory changes, patent expiries, and evolving healthcare demands. Abbott India’s ability to maintain a positive three- and five-year return relative to the Sensex (38.03% and 89.94%, respectively) underscores its resilience and strategic positioning.

However, the negative one-year return of -11.02% compared to the Sensex’s 8.39% gain highlights recent headwinds, possibly linked to sector-specific disruptions or company-specific factors. The current technical momentum shift may signal the beginning of a recovery phase, but investors should remain vigilant.

Investor Takeaway and Outlook

Abbott India Ltd.’s recent technical parameter changes indicate a tentative shift from bearish to mildly bearish momentum, suggesting that the stock may be entering a consolidation or early recovery phase. The mixed signals from MACD, RSI, moving averages, and volume-based indicators call for a cautious but attentive approach.

Short-term traders might find opportunities in the current volatility, especially if the stock breaks above key moving averages or the upper Bollinger Band. Long-term investors should weigh the company’s solid multi-year returns and sector positioning against recent underperformance and technical uncertainty.

Overall, the upgrade to a Hold rating by MarketsMOJO reflects a balanced view, recognising improving conditions while acknowledging ongoing risks. Monitoring upcoming quarterly results, sector developments, and technical confirmations will be crucial for making informed investment decisions.

Summary of Key Technical Metrics:

• MACD: Weekly Bearish, Monthly Mildly Bearish
• RSI: Neutral (No Signal) on Weekly and Monthly
• Bollinger Bands: Mildly Bearish on Weekly and Monthly
• Moving Averages: Daily Mildly Bearish
• KST: Weekly Bearish, Monthly Mildly Bearish
• Dow Theory: Mildly Bearish on Weekly and Monthly
• OBV: Weekly Mildly Bearish, Monthly No Trend

With a current price of ₹27,818.15 and a recent day gain of 3.69%, Abbott India remains a stock to watch closely as it navigates technical inflection points amid a challenging pharmaceutical landscape.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today